Moderna vaccine shows promising early results
“One of Moderna’s directors, Moncef Slaoui — who owns
millions in company stock options — days ago left his role to become chief
scientist for a White House vaccine initiative”.
Washington Post reports:
“The company reported that in eight patients who had
been followed for a month and a half, the vaccine at low and medium doses
triggered blood levels of virus-fighting antibodies that were similar or
greater than those found in patients who recovered. That would suggest, but
doesn’t prove, that it triggers some level of immunity”.
Earlier Examples –
He Was a Science Star. Then He Promoted a
Questionable Cure for Covid-19.
The Politics of Hydroxychloroquine